Trending Topic

virus closeup, contagious pathogen. Monkey pox virus closeup, contagious pathogen, infectious zoonotic disease
7 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

A double-stranded DNA virus of the Orthopoxvirus family, mpox (formerly monkeypox), continues to infect people daily, following the 2022 global outbreak.1 Two clades (clade 1 and clade 2) have been identified, with the 2022 outbreak caused by a subclade of clade 2, referred to as clade 2b.2 Comparatively, clade 1 leads to a more severe disease state and greater […]

Published Online: Jun 9th 2025

World Vaccine Congress - NFIA

The World Vaccine Congress Washington 2025, 21-24 April 2025, delivered another landmark year, bringing together more than 4,000 global stakeholders from biotechnology, pharmaceuticals, government, academia and the broader global health ecosystem. The event reinforced its standing as an influential and collaborative forum in the vaccine research and development space.

“WVC is not just a conference, it is a movement towards global vaccine equity and innovation.”

Dr Patrick Slaine, Chrysaor Biologicals

 

Key presentations and sessions

Opening plenary: Defending science in the age of disinformation

Dr Greg Poland (Mayo Vaccine Research Group) opened the Congress with a passionate appeal for transparency and science-based dialogue in response to global vaccine scepticism.

Thematic tracks across the vaccine lifecycle

Twelve content tracks explored cutting-edge science and critical operational topics. The core tracks included:

Track Focus area
R&D innovation RNA platforms, novel adjuvants, alternative vaccine targets
Manufacturing and CMC Sustainable production, process optimisation
Clinical trials and regulation Real-world evidence, trial design, regulatory harmonization
Immunisation programmes Maternal vaccines, human papillomavirus (HPV) elimination, RSV infant immunization
Global health Neglected tropical diseases, parasitic diseases, regional preparedness
Emerging threats Mpox, antimicrobial resistance, biodefence strategies

Pre-congress workshops included:

  • RNA vaccines and delivery systems
  • Vaccine R&D for parasitic and neglected diseases
  • RSV infant immunization & maternal vaccines
  • Global mpox response & HPV elimination strategies
  • Enhancing Korea’s vaccine R&D capacity
  • Innovation in non-traditional antigen targets

Notable sessions tackled misinformation, pandemic readiness, and regional manufacturing resilience – vital topics as the world moves toward long-term preparedness.

Thought leaders defining the agenda

This year’s congress featured more than 30 keynote speakers shaping the future of global vaccine policy and practice. Some of the highlights included:

  • Dr Stanley Plotkin (University of Pennsylvania, USA), was honoured with the Lifetime Achievement Award for his decades-long contribution to vaccine development and infectious disease research.
  • Dr Seth Berkley (Pandemic Center, Brown University, USA), former CEO of Gavi, The Vaccine Alliance, spoke on global financing mechanisms and equitable access during pandemics.
  • Dr Maria Elena Bottazzi (Texas Children’s Hospital, USA) addressed strategies for improving local vaccine production capacity and accessibility in underserved regions.
  • Dr Saad Omer (University of Texas Southwestern, USA) focused on restoring public trust in vaccines amidst rising misinformation.
  • Dr Tonya Villafana (AstraZeneca), Dr Francesca Ceddia (Moderna) and Dr Alejandra Gurtman (Pfizer) provided updates on RSV prevention, HPV vaccine strategy and mRNA-based immunotherapy development.
  • Dr Ahmed Ogwell (United Nations Foundation) and Dr Hannah Kettler (GAVI) contributed perspectives on sustainable manufacturing and pandemic preparedness across regions.

Full speaker list here

“The range of expertise from clinical research to public health policy makes this event unmatched.”

– Ruchir Rastogi, Premas Biotech

Honours and highlights: VIE Awards 2025

This year’s Vaccine Industry Excellence (VIE) Awards recognized outstanding contributions from across the field:

Category Winner
Best pharmaceutical company BioNTech
Best biotechnology company Valneva
Best clinical trial organisation EmVenio Research
Best academic team Dr Adrian Hill, University of Oxford
Best prophylactic vaccine Merck – Gardasil 9
Best therapeutic vaccine Merck and Moderna – mRNA-4157
Vaccine advocate of the year Dr Peter Hotez

Powered by purpose: Sustainability at WVC

In line with its commitment to sustainability and accessibility, the 2025 Congress implemented several initiatives:

  • A fully paperless programme, delivered via the event app
  • Hosted at a LEED Platinum-certified venue in Washington DC
  • Partnerships with ISO 14001-certified contractors (e.g. Freeman)
  • Carbon emissions tracking using the Trace platform
  • Encouragement of eco-certified hotel bookings and public transport

Mark your calendar

World Vaccine Congress Europe 2025
13 – 16 October 2025
RAI Amsterdam Convention Centre, Amsterdam
Register now and use touchINFECTIOUS DISEASES promo code for 20% off: TID20

World Vaccine Congress Washington 2026
30 March – 2 April 2026
Walter E. Washington Convention Center, Washington D.C.
Register now and use touchINFECTIOUS DISEASES promo code for 20% off: TID20

 

Editor: Katey Gabrysch

Disclosure: This article was created by the touchINFECTIOUS DISEASES team utilizing AI as an editorial tool (ChatGPT (GPT-4o) [Large language model]. https://chat.openai.com/chat.) The content was developed and edited by human editors. No funding was received in the publication of this article.

Cite: World Vaccine Congress Washington 2025 #WVCDC: Highlights

SIGN UP to touchINFECTIOUS DISEASES!

Join our global community today for access to thousands of peer-reviewed articles, expert insights, and learn-on-the-go education across 150+ specialties, plus concise email updates and newsletters so you never miss out.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup